10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
Effect of hemodiafiltration or hemodialysis on mortality in kidney failure
PJ Blankestijn, RWM Vernooij… - … England Journal of …, 2023 - Mass Medical Soc
Background Several studies have suggested that patients with kidney failure may benefit
from high-dose hemodiafiltration as compared with standard hemodialysis. However, given …
from high-dose hemodiafiltration as compared with standard hemodialysis. However, given …
Hot weather and heat extremes: health risks
Hot ambient conditions and associated heat stress can increase mortality and morbidity, as
well as increase adverse pregnancy outcomes and negatively affect mental health. High …
well as increase adverse pregnancy outcomes and negatively affect mental health. High …
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
Background Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has
favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 …
favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 …
Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
Pathophysiology of COVID-19-associated acute kidney injury
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …
kidney involvement is also common. Available evidence supports a number of potential …
Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options
J Jankowski, J Floege, D Fliser, M Böhm, N Marx - Circulation, 2021 - Am Heart Assoc
Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk
manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac …
manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac …
Epidemiology of haemodialysis outcomes
Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
Hypertension as cardiovascular risk factor in chronic kidney disease
M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …
global targets of World Health Organization for prevention. Hypertension also affects the …